Renaissance Technologies’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-87,886
Closed -$235K 3526
2025
Q1
$235K Buy
87,886
+26,726
+44% +$71.4K ﹤0.01% 3025
2024
Q4
$215K Buy
61,160
+25,300
+71% +$89.1K ﹤0.01% 3145
2024
Q3
$170K Buy
35,860
+10,800
+43% +$51.2K ﹤0.01% 3156
2024
Q2
$118K Buy
25,060
+14,360
+134% +$67.5K ﹤0.01% 3155
2024
Q1
$49K Sell
10,700
-200
-2% -$916 ﹤0.01% 3489
2023
Q4
$45K Sell
10,900
-11,200
-51% -$46.2K ﹤0.01% 3472
2023
Q3
$95K Sell
22,100
-17,500
-44% -$75.2K ﹤0.01% 3258
2023
Q2
$206K Sell
39,600
-2,000
-5% -$10.4K ﹤0.01% 3294
2023
Q1
$283K Buy
41,600
+2,400
+6% +$16.3K ﹤0.01% 3150
2022
Q4
$96K Buy
39,200
+500
+1% +$1.22K ﹤0.01% 3631
2022
Q3
$128K Sell
38,700
-1,000
-3% -$3.31K ﹤0.01% 3514
2022
Q2
$194K Buy
39,700
+14,500
+58% +$70.9K ﹤0.01% 3664
2022
Q1
$191K Buy
25,200
+1,400
+6% +$10.6K ﹤0.01% 3664
2021
Q4
$185K Buy
23,800
+1,200
+5% +$9.33K ﹤0.01% 3536
2021
Q3
$192K Sell
22,600
-54,360
-71% -$462K ﹤0.01% 3216
2021
Q2
$691K Buy
76,960
+54,899
+249% +$493K ﹤0.01% 2823
2021
Q1
$255K Buy
+22,061
New +$255K ﹤0.01% 3098
2020
Q3
Sell
-24,962
Closed -$198K 3338
2020
Q2
$198K Sell
24,962
-10,693
-30% -$84.8K ﹤0.01% 3165
2020
Q1
$233K Buy
35,655
+18,542
+108% +$121K ﹤0.01% 3060
2019
Q4
$181K Buy
17,113
+5,155
+43% +$54.5K ﹤0.01% 3216
2019
Q3
$407K Sell
11,958
-4,105
-26% -$140K ﹤0.01% 2940
2019
Q2
$620K Buy
16,063
+1,780
+12% +$68.7K ﹤0.01% 2911
2019
Q1
$923K Buy
14,283
+1,690
+13% +$109K ﹤0.01% 2708
2018
Q4
$305K Buy
12,593
+4,240
+51% +$103K ﹤0.01% 3020
2018
Q3
$526K Buy
8,353
+5,626
+206% +$354K ﹤0.01% 2830
2018
Q2
$206K Buy
2,727
+1,803
+195% +$136K ﹤0.01% 3065
2018
Q1
$235K Buy
924
+110
+14% +$28K ﹤0.01% 3143
2017
Q4
$219K Buy
814
+323
+66% +$86.9K ﹤0.01% 3106
2017
Q3
$199K Buy
491
+34
+7% +$13.8K ﹤0.01% 3000
2017
Q2
$362K Sell
457
-6
-1% -$4.75K ﹤0.01% 2851
2017
Q1
$450K Sell
463
-7
-1% -$6.8K ﹤0.01% 2801
2016
Q4
$517K Buy
470
+57
+14% +$62.7K ﹤0.01% 2749
2016
Q3
$460K Buy
413
+15
+4% +$16.7K ﹤0.01% 2843
2016
Q2
$876K Buy
398
+31
+8% +$68.2K ﹤0.01% 2592
2016
Q1
$551K Buy
367
+23
+7% +$34.5K ﹤0.01% 2824
2015
Q4
$916K Buy
344
+18
+6% +$47.9K ﹤0.01% 2500
2015
Q3
$1.6M Sell
326
-54
-14% -$265K ﹤0.01% 2123
2015
Q2
$1.95M Buy
380
+93
+32% +$477K ﹤0.01% 2078
2015
Q1
$1.36M Buy
287
+112
+64% +$529K ﹤0.01% 2147
2014
Q4
$883K Buy
175
+68
+64% +$343K ﹤0.01% 2181
2014
Q3
$631K Sell
107
-20
-16% -$118K ﹤0.01% 2231
2014
Q2
$1.04M Buy
127
+86
+210% +$707K ﹤0.01% 2031
2014
Q1
$1.05M Buy
41
+2
+5% +$51.4K ﹤0.01% 2056
2013
Q4
$707K Buy
39
+15
+63% +$272K ﹤0.01% 2236
2013
Q3
$484K Buy
24
+9
+60% +$182K ﹤0.01% 2304
2013
Q2
$324K Buy
+15
New +$324K ﹤0.01% 2392